Valentina Robila

485 total citations
25 papers, 359 citations indexed

About

Valentina Robila is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Valentina Robila has authored 25 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Valentina Robila's work include Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Valentina Robila is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Valentina Robila collaborates with scholars based in United States, Canada and Mexico. Valentina Robila's co-authors include Víctor H. Engelhard, Marina Ostankovitch, Michael O. Idowu, Timothy N. J. Bullock, Teresa A. Colella, David W. Mullins, Steven C. Smith, Rania Bassiouni, Paula D. Bos and Michael O. Idowu and has published in prestigious journals such as The Journal of Immunology, Cancer Research and CHEST Journal.

In The Last Decade

Valentina Robila

22 papers receiving 358 citations

Peers

Valentina Robila
Jessie Brown United States
Valerie J. Ludbrook United Kingdom
Joo Hyoung Lee United States
Bogang Wu United States
Jessie Brown United States
Valentina Robila
Citations per year, relative to Valentina Robila Valentina Robila (= 1×) peers Jessie Brown

Countries citing papers authored by Valentina Robila

Since Specialization
Citations

This map shows the geographic impact of Valentina Robila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Robila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Robila more than expected).

Fields of papers citing papers by Valentina Robila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentina Robila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Robila. The network helps show where Valentina Robila may publish in the future.

Co-authorship network of co-authors of Valentina Robila

This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Robila. A scholar is included among the top collaborators of Valentina Robila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Robila. Valentina Robila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Hanming, Valentina Robila, Matthew S. Halquist, et al.. (2025). An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable. International Journal of Pharmaceutics. 673. 125372–125372.
2.
Robila, Valentina, et al.. (2025). Piezo2 Is a Key Mechanoreceptor in Lung Fibrosis that Drives Myofibroblast Differentiation. American Journal Of Pathology. 195(4). 626–638. 7 indexed citations
3.
Yang, Lu, Arup Bhattacharya, Darrell L. Peterson, et al.. (2024). Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models. Drug Resistance Updates. 74. 101078–101078. 9 indexed citations
4.
Kolominsky, Jeffrey, Andrew Poklepovic, Aamer Syed, et al.. (2023). Granulomatous Cardiomyopathy Presenting As a Paraneoplastic Syndrome in Metastatic Melanoma. CJC Open. 5(9). 713–716. 1 indexed citations
5.
Tang, Amy, Richard Hoefer, Dasom Lee, et al.. (2023). Abstract 5531: Early detection of cancer disparity and treatment resistance in TNBC. Cancer Research. 83(7_Supplement). 5531–5531. 1 indexed citations
6.
Bassiouni, Rania, Michael O. Idowu, Lee D. Gibbs, et al.. (2022). Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer. Cancer Research. 83(1). 34–48. 46 indexed citations
7.
Bassiouni, Rania, Michael O. Idowu, Lee D. Gibbs, et al.. (2022). Abstract 2032: Comprehensive spatial transcriptomic analysis of an integrated, diverse cohort reveals distinct molecular topographic patterns in triple negative breast cancer. Cancer Research. 82(12_Supplement). 2032–2032. 1 indexed citations
8.
Compton, Margaret, Vivian Weiß, Yonca Kanber, et al.. (2022). Adrenal gland cytology reporting: a multi‐institutional proposal for a standardized reporting system. Cancer Cytopathology. 130(6). 423–432. 3 indexed citations
9.
Hoover, Kevin B., et al.. (2021). Quantitative contrast enhanced dual energy CT to predict avascular necrosis: a feasibility study of proximal humerus fractures. BMC Medical Imaging. 21(1). 191–191. 3 indexed citations
11.
Robila, Valentina, et al.. (2021). ESTROGEN AND PROGESTERONE RECEPTOR EXPRESSION IN TRACHEAL MUCOSA OF PATIENTS WITH IDIOPATHIC SUBGLOTTIC STENOSIS. CHEST Journal. 160(4). A1759–A1759. 1 indexed citations
12.
Robila, Valentina, et al.. (2021). Fine needle aspiration and core needle biopsy of the spleen: A case series illustrating current practices and challenges. Diagnostic Cytopathology. 49(11). 1196–1206. 5 indexed citations
13.
Martinez, Leandro Marcelo, et al.. (2019). Regulatory T Cells Control the Switch From in situ to Invasive Breast Cancer. Frontiers in Immunology. 10. 1942–1942. 36 indexed citations
14.
Robila, Valentina, et al.. (2019). New entities, new technologies, new findings: A review of the cytologic features of recently established subtypes of renal cell carcinoma. Cancer Cytopathology. 127(2). 79–97. 14 indexed citations
15.
Khurana, Arushi, Valentina Robila, H. Davis Massey, & Asit K. Paul. (2019). Paraneoplastic Glomerulonephropathy Associated With Renal Cell Carcinoma. JCO Oncology Practice. 16(2). 87–89. 2 indexed citations
16.
Shyu, Irene, Leili Mirsadraei, Xiaoyan Wang, et al.. (2018). Clues to recognition of fumarate hydratase‐deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples. Cancer Cytopathology. 126(12). 992–1002. 13 indexed citations
17.
Idowu, Michael O., et al.. (2018). Interobserver Variability in Scoring Percentages of Tumor-Infiltrating Lymphocytes in Breast Core Needle Biopsies. American Journal of Clinical Pathology. 150(suppl_1). S27–S28. 1 indexed citations
18.
Zhao, Min, Patrick C. Sachs, Xu Wang, et al.. (2012). Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type. Cancer Biology & Therapy. 13(9). 782–792. 61 indexed citations
19.
Robila, Valentina, Marina Ostankovitch, Alexander C. Theos, et al.. (2008). MHC Class II Presentation of gp100 Epitopes in Melanoma Cells Requires the Function of Conventional Endosomes and Is Influenced by Melanosomes. The Journal of Immunology. 181(11). 7843–7852. 37 indexed citations
20.
Mullins, David W., Timothy N. J. Bullock, Teresa A. Colella, Valentina Robila, & Víctor H. Engelhard. (2001). Immune Responses to the HLA-A*0201-Restricted Epitopes of Tyrosinase and Glycoprotein 100 Enable Control of Melanoma Outgrowth in HLA-A*0201-Transgenic Mice. The Journal of Immunology. 167(9). 4853–4860. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026